This track will explore the latest advancements in diagnostic techniques for glomerular diseases. Emphasis will be placed on novel biomarkers and imaging modalities that enhance early detection and accurate diagnosis.

This session will delve into the underlying mechanisms of glomerular diseases, focusing on cellular and molecular pathways. Discussions will include the role of inflammation, immune response, and genetic factors in disease progression.

This track will address contemporary strategies for the clinical management of glomerulonephritis. Topics will include treatment protocols, patient monitoring, and the integration of multidisciplinary approaches in care.

This session will highlight the significance of renal biomarkers in the diagnosis and management of kidney diseases. Participants will explore the utility of biomarkers in predicting disease progression and treatment response.

This track will focus on methodologies for assessing kidney function and strategies for its preservation in patients with glomerular diseases. Emphasis will be placed on lifestyle interventions and pharmacological approaches.

This session will review cutting-edge therapeutic options for glomerular diseases, including novel pharmacological agents and biologics. Discussions will encompass clinical trial outcomes and future directions in nephrology.